Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06611397 · ClinicalTrials.gov registry record · NA
Discogen for Low Back Pain
A NA study of Disc Herniation, sponsored by Columbia University.
- Recruiting
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT06611397: Recruiting NA study of Disc Herniation, sponsored by Columbia University.
NCT06611397 is a NA study of Disc Herniation that is actively recruiting participants, run by Columbia University. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06611397, a NA study of Disc Herniation, is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will be a double-blinded, two-arm, prospective, randomized controlled pilot feasibility study in 40 evaluable subjects (20 in each arm) at one study site within the United States. Subjects in Arm 1 will receive unilateral Discogen treatment; subjects in Arm 2 will receive unilateral sham treatment (control). Treatment in both arms can include medications, e.g. NSAIDs or muscle relaxants for axial or radicular pain.
Primary Outcome
Percent change from baseline for Numerical Pain Scale (NPS) radicular leg pain at 30 and 60 days. The NPS is a patient-reported assessment of pain intensity, ranging from 0 (No pain) to 10 (Severe pain).
Conditions Studied
Interventions
- DEVICE Discogen Low pulsed ultrasound treatment
- DEVICE Discogen Sham Treatment
Study Locations (1)
New York
- Columbia University Irving Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2025-03-15 |
| Est. Completion | 2027-03-01 |
| Phase | NA |
What NCT06611397 shows while recruiting
NCT06611397 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Disc Herniation appearing as the primary indexed condition, and to 2 interventions - of which Discogen Low pulsed ultrasound treatment is the first listed.
NCT06611397 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06611397 about?
NCT06611397 is a clinical study titled "Discogen for Low Back Pain". This study will be a double-blinded, two-arm, prospective, randomized controlled pilot feasibility study in 40 evaluable subjects (20 in each arm) at one study site within the United States. Subjects in Arm 1 will receive unilateral Discogen treatment; subjects in Arm 2 will receive unilateral sham ...
What is the current status of trial NCT06611397?
This trial is currently recruiting. It is a NA study. The enrollment target is 5 participants. The study started on 2025-03-15. Estimated completion is 2027-03-01.
What conditions does trial NCT06611397 study?
This clinical trial studies the following conditions: Disc Herniation.
What interventions are being tested in trial NCT06611397?
The interventions under investigation include: Discogen Low pulsed ultrasound treatment (DEVICE), Discogen Sham Treatment (DEVICE).
Who is sponsoring clinical trial NCT06611397?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06611397 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Disc Herniation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06611397's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI